Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

NCT06072612 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

404

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer
Metastatic Breast Cancer
Breast Neoplasm
Breast Cancer Metastatic
End Stage Cancer

Interventions

BIOLOGICAL: SV-BR-1-GM
DRUG: Cyclophosphamide
DRUG: Interferon infiltration of the inoculation site
DRUG: Retifanlimab
DRUG: Treatment of Physician's Choice

Sponsor

BriaCell Therapeutics Corporation